These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 5513338)

  • 1. [Clinical experiences with Cinnarizin (Stugeron) in the treatment of arteriosclerotic and post-traumatic psychosyndromes].
    Voina S
    Schweiz Rundsch Med Prax; 1970 Aug; 59(32):1165-70. PubMed ID: 5513338
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical responses to Cinnarizin in various psychiatric syndromes.
    Szobor A; Klein M
    Ther Hung; 1973; 21(1):31-4. PubMed ID: 4792889
    [No Abstract]   [Full Text] [Related]  

  • 3. [Use of sordinol in mental disordes of vascular origin].
    Romanova IS; Banshchikov VM; Rozhanets RV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1968; 68(8):1223-8. PubMed ID: 5700590
    [No Abstract]   [Full Text] [Related]  

  • 4. [On the circulatory physiology and biochemistry of cerebral degeneration processes and influencing the behavior of patients with drug therapy].
    Cornu F
    Wien Klin Wochenschr; 1969 Jun; 81(23):426-31. PubMed ID: 5790194
    [No Abstract]   [Full Text] [Related]  

  • 5. Psychopharmacological treatment of disorders of senescence.
    Fann WE; Wheless JC; Richman BW
    N C Med J; 1974 Nov; 35(11):672-7. PubMed ID: 4530160
    [No Abstract]   [Full Text] [Related]  

  • 6. [On the use of cinnarizine dihydrochloride in the treatment of arteriosclerotic cerebropathy].
    Di Lorenzo S; Costagliola A; Lampasi D; Alfano S
    Minerva Cardioangiol; 1974 Dec; 22(12):867-70. PubMed ID: 4459730
    [No Abstract]   [Full Text] [Related]  

  • 7. [Experimental investigations on drug induced improvement of brain metabolism].
    Köhler W
    Wien Klin Wochenschr; 1972 May; 84(21):340-3. PubMed ID: 5064086
    [No Abstract]   [Full Text] [Related]  

  • 8. [The use of Floristen and Lyastin in arteriosclerotic affection of the brain (author's transl)].
    Pavlovský P; Hanáková B; Petránová V
    Cesk Psychiatr; 1979 Apr; 75(2):118-21. PubMed ID: 546515
    [No Abstract]   [Full Text] [Related]  

  • 9. Papaverin in the treatment of geriatric patients.
    Bambasová E; Bílková J; Budínská K
    Act Nerv Super (Praha); 1974 Aug; 16(3):191-2. PubMed ID: 4609360
    [No Abstract]   [Full Text] [Related]  

  • 10. An evaluation of the permanence of the "tardive dyskinesias".
    Paulson GW
    Dis Nerv Syst; 1968 Oct; 29(10):692-4. PubMed ID: 5717285
    [No Abstract]   [Full Text] [Related]  

  • 11. [Therapeutic results with 1035 MD (apropos of 92 cases)].
    Delteil P; Douche F; Fromentin M
    Ann Med Psychol (Paris); 1971 Feb; 1(2):261-8. PubMed ID: 5577431
    [No Abstract]   [Full Text] [Related]  

  • 12. Results obtained with Sturgeron applied in progressive cerebral arteriosclerosis patients controlled systematically for years.
    Hunyi L
    Ther Hung; 1974; 22(1):32-4. PubMed ID: 4844929
    [No Abstract]   [Full Text] [Related]  

  • 13. [Aescin (=Reparil) in cerebral circulation disorders. Clinical and ophthalmodynamographic observations].
    Tzavellas O; Finke J
    Wien Klin Wochenschr; 1970 Oct; 82(41):714-6. PubMed ID: 5529668
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effectiveness of methods of treating atherosclerotic psychoses and several indices of the blood coagulation system].
    Gorodilova EP
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1976; 76(6):911-6. PubMed ID: 952160
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical experiences with noxiptilin].
    König L; Lange E; Rossner M; Liefke T; Uhlig B; Kursawe HK; Lungwitz J
    Psychiatr Neurol Med Psychol (Leipz); 1976 Apr; 28(4):236-42. PubMed ID: 947276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of cerebro-organic changes due to age with kavaform].
    Kurz JF
    Landarzt; 1968 Aug; 44(23):iv-xii. PubMed ID: 4883272
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical ophthalmodynamographic results of the treatment of cerebral circulation disorders with O-(beta-hydroxyethyl)-rutoside].
    Tzavellas O
    Arzneimittelforschung; 1970 Sep; 20(9):1187-90. PubMed ID: 5536794
    [No Abstract]   [Full Text] [Related]  

  • 18. Differential effects of trazodone in depressed, schizophrenic and geriatric patients.
    Ban TA; Lehmann HE; Amin M; Bronheim LA; Klingner A; Nair NP; Galvan L; Vergara L; Zoch C
    Int J Clin Pharmacol; 1974 Jan; 9(1):23-7. PubMed ID: 4593127
    [No Abstract]   [Full Text] [Related]  

  • 19. [Experiences on the treatment of cerebral insufficiency and peripheral circulation disorders with the test preparation EP 50-100].
    Bock KJ
    Med Welt; 1972 Feb; 23(8):273-5. PubMed ID: 5012543
    [No Abstract]   [Full Text] [Related]  

  • 20. [Can disorders of cerebral performance be improved by drugs? Use of vaso- and metabolically active substances in primary degenerative brain diseases and cerebral arteriosclerosis].
    Herrschaft H
    Fortschr Med; 1987 Nov; 105(32):637-40. PubMed ID: 3323002
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.